Back to Journals » International Journal of Nanomedicine » Volume 9 » Issue 1

Folate-targeted paclitaxel-conjugated polymeric micelles inhibits pulmonary metastatic hepatoma in experimental murine H22 metastasis models

Authors Zhang Y, Zhang H, Wu WB, Zhang FH, Liu S, Wang R, Sun YC, Tong T, Jing XB

Received 18 November 2013

Accepted for publication 10 January 2014

Published 23 April 2014 Volume 2014:9(1) Pages 2019—2030

DOI https://doi.org/10.2147/IJN.S57744

Checked for plagiarism Yes

Review by Single-blind

Peer reviewer comments 3

Yan Zhang,1 Hui Zhang,2 Wenbin Wu,2 Fuhong Zhang,3,4 Shi Liu,3 Rui Wang,3 Yingchun Sun,1 Ti Tong,1 Xiabin Jing3

1Department of Thoracic Surgery, The Second Hospital of Jilin University, Changchun, Jilin, People's Republic of China; 2Department of Thoracic Surgery, Xuzhou Central Hospital, Xuzhou, Jiangsu, People's Republic of China; 3State Key Laboratory of Polymer Physics and Chemistry, Changchun Institute of Applied Chemistry, Chinese Academy of Sciences, Changchun, Jilin, People's Republic of China; 4Department of Otolaryngology, The First Hospital of Lanzhou University, Lanzhou, Gansu, People's Republic of China

Abstract: Hepatocellular carcinoma shows low response to most conventional chemotherapies; additionally, extrahepatic metastasis from hepatoma is considered refractory to conventional systemic chemotherapy. Target therapy is a promising strategy for advanced hepatoma; however, targeted accumulation and controlled release of therapeutic agents into the metastatic site is still a great challenge. Folic acid (FA) and paclitaxel (PTX) containing composite micelles (FA-M[PTX]) were prepared by coassembling the FA polymer conjugate and PTX polymer conjugate. The main purpose of this study is to investigate the inhibitory efficacy of FA-M(PTX) on the pulmonary metastasis of intravenously injected murine hepatoma 22 (H22) on BALB/c mice models. The lung metastatic burden of H22 were measured and tissues were analyzed by immunohistochemistry and histology (hematoxylin and eosin stain), followed by survival analysis. The results indicated that FA-M(PTX) prevented pulmonary metastasis of H22, and the efficacy was stronger than pure PTX and simple PTX-conjugated micelles. In particular, the formation of lung metastasis colonies in mice was evidently inhibited, which was paralleled with the downregulated expression of matrix metalloproteinase-2 and matrix metalloproteinase-9. Furthermore, the mice bearing pulmonary metastatic hepatoma in the FA-M(PTX) group gained significantly prolonged survival time when compared with others given equivalent doses of PTX of 30 mg/kg. The enhanced efficacy of FA-M(PTX) is theoretically ascribed to the target effect of FA; moreover, the extensive pulmonary capillary networks may play a role. In conclusion, FA-M(PTX) displayed great potential as a promising antimetastatic agent, and the FA-conjugated micelles is a preferential targeted delivery system when compared to micelles without FA.

Keywords: pulmonary metastasis, folate receptor, paclitaxel, polymer–drug conjugate, targeted drug delivery


Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]

 

Other article by this author:

Antitumor activity of folate-targeted, paclitaxel-loaded polymeric micelles on a human esophageal EC9706 cancer cell line

Wu WB, Zheng YH, Wang R, Huang WL, Liu L, Hu XL, Liu S, Yue J, Tong T, Jing XB

International Journal of Nanomedicine 2012, 7:3487-3502

Published Date: 6 July 2012

Readers of this article also read:

Delivery as nanoparticles reduces imatinib mesylate-induced cardiotoxicity and improves anticancer activity

Marslin G, Revina AM, Khandelwal VKM, Balakumar K, Prakash J, Franklin G, Sheeba CJ

International Journal of Nanomedicine 2015, 10:3163-3170

Published Date: 24 April 2015

Polymersomes containing quantum dots for cellular imaging

Camblin M, Detampel P, Kettiger H, Wu D, Balasubramanian V, Huwyler J

International Journal of Nanomedicine 2014, 9:2287-2298

Published Date: 12 May 2014

Novel designed polyoxyethylene nonionic surfactant with improved safety and efficiency for anticancer drug delivery

Li C, Sun C, Li S, Han P, Sun H, Ouahab A, Shen Y, Xu Y, Xiong Y, Tu J

International Journal of Nanomedicine 2014, 9:2089-2100

Published Date: 28 April 2014

Targeted nanotherapeutics in cancer

Shiekh FA

International Journal of Nanomedicine 2014, 9:1627-1628

Published Date: 26 March 2014

The use of nanoencapsulation to decrease human skin irritation caused by capsaicinoids

Contri RV, Frank LA, Kaiser M, Pohlmann AR, Guterres SS

International Journal of Nanomedicine 2014, 9:951-962

Published Date: 12 February 2014

Tissue inhibitor of matrix metalloproteinases-1 loaded poly(lactic-co-glycolic acid) nanoparticles for delivery across the blood–brain barrier

Chaturvedi M, Molino Y, Sreedhar B, Khrestchatisky M, Kaczmarek L

International Journal of Nanomedicine 2014, 9:575-588

Published Date: 20 January 2014

Biscarbamate cross-linked polyethylenimine derivative with low molecular weight, low cytotoxicity, and high efficiency for gene delivery

Wang YQ, Su J, Wu F, Lu P, Yuan LF, Yuan WE, Sheng J, Jin T

International Journal of Nanomedicine 2012, 7:693-704

Published Date: 9 February 2012